{"disease":{"id":"moderate-to-severe-chronic-pain","name":"moderate to severe chronic pain"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02603705","title":"Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Egalet Ltd","has_results":false},{"nct_id":"NCT06091020","title":"A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Merz Therapeutics GmbH","has_results":false},{"nct_id":"NCT03802227","title":"A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Nektar Therapeutics","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}